San Diego, CA, United States of America

Tom Lin

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Lin Bioscience Inc., Lin Bioscience Pty Ltd.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tom Lin. Retrieved from https://idiyas.com/inventor/tom-lin-azl99xuv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tom Lin in Cancer Treatment

Introduction

Tom Lin is an accomplished inventor based in San Diego, CA, known for his significant contributions to the field of cancer treatment. With a total of 2 patents to his name, Lin has focused on developing innovative solutions that target critical health issues.

Latest Patents

Among his latest patents are tubulin inhibitors, which provide compounds, pharmaceutical compositions, and methods of treatment for various diseases, particularly cancer. These methods specifically address the treatment of brain cancers and metastatic cancers that spread to the brain, showcasing Lin's commitment to advancing medical science.

Career Highlights

Lin is associated with Lin Bioscience Pty Ltd., where he continues to work on groundbreaking research and development in the pharmaceutical field. His work is pivotal in creating effective treatments that can potentially save lives.

Collaborations

Some of his notable coworkers include Cheng-Chi Irene Wang and Jason Olejniczak, who contribute to the innovative environment at Lin Bioscience Pty Ltd. Their collaboration enhances the research efforts and accelerates the development of new therapies.

Conclusion

Tom Lin's work in developing tubulin inhibitors represents a significant advancement in cancer treatment. His dedication to innovation and collaboration in the field of pharmaceuticals is commendable and holds promise for future breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…